Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study
Posadas, Edwin M., Ahmed, Rafi S., Karrison, Theodore, Szmulewitz, Russell Z., O'Donnell, Peter H., Wade, James L., Shen, James, Gururajan, Murali, Sievert, Margarit, Stadler, Walter M.Volume:
76
Language:
english
Journal:
The Prostate
DOI:
10.1002/pros.23119
Date:
February, 2016
File:
PDF, 197 KB
english, 2016